Patent and Data Protection in the Pharmaceutical Industry
23 April 2015
Bringing a new drug to market requires a great deal of investment in research and development. Vivian Y. F. Chen looks at what patent holders can do in Taiwan to extend data protection and enhance return on investment.
To continue reading this article, please Login or Register to be a subscriber